List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 6 studies with search of:   "Morphotek" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: MORAb-009;   Drug: Gemcitabine
2 Completed Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Drug: MORAb-003
3 Active, not recruiting Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Neoplasms
Intervention: Drug: MORAb-003
4 Recruiting An Efficacy Study of MORAb-009 in Subjects With Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: MORAb-009 given on days 1 and 8 of each 21 day treatment cycle.
5 Completed A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
Conditions: Pancreatic Cancer;   Mesothelioma;   Ovarian Cancer;   Non-Small Cell Lung Cancer
Intervention: Drug: MORAb-009
6 Recruiting An Efficacy and Safety Study of MORAb-003 in First Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: MORAb-003 (farletuzumab);   Drug: 0.9% Saline

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services